{"database": "lobbying", "table": "lobbying_activities", "rows": [[2179531, "4d93e9e1-902b-4f97-980a-bdd5312e3704", "Q3", "RED+BLUE STRATEGIES", 400693064, "EXPRESS SCRIPTS INC.", 2018, "third_quarter", "PHA", "S. 2553 - Know the Lowest Price Act of 2018- Support of the elimination of \"gag clauses\" in Medicare Part D.\n\nS. 2554 - Patient Right to Know Act - Support of the elimination of \"gag clauses\" in private market drug benefits.\n\nH.R. 6 - Support for Patients and Communities Act - Issues related to ensuring safe prescribing of opioids and other pharmaceuticals that can drive addiction.\n\nS. 3120 - Helping to End Addition and Lessen Substance Use Disorders Act - Issues related to ensuring safe prescribing of opioids and other pharmaceuticals that can drive addiction.\n\nS. 2460/H.R. 3528 - Every Prescription Conveyed Securely Act - support for a bill that would require electronic prescribing for opioids.\n\nCMS regulations related to the Medicare Part D program and role of Prescription Drug Plans. \n\nS. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices.\n\nS. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars. \n\nH.R. 3447 - Furthering Access to Coordinated Treatment for Seniors (FACTS) Act of 2017 - Working to explain the need for safe and confidential data sharing between Medicare part A, B, and D to ensure better coordination of patient care.\n\nIssues related to Direct and Indirect Renumeration policies and their impact on consumers. \n\nThe Trump Administration's Blueprint for Controlling Prescription Drug Prices - Issues related to the role PBMs can play in controlling the price of prescription medications in the United States.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2018-10-02T15:21:15.300000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2179531"], "units": {}, "query_ms": 8.849392994306982, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}